Background: According to the World Health Organization, Myopia is already one of the major causes of vision impairment and blindness. It is predicted to affect almost a half of the world's population within the next years. A lot of researches around the world have been performed on Myopia, there is no clear overview of these researchers. In this manuscript, we analyzed the main connections between the most cited researchers, to build a citation network to evaluate the impact of different authors, journals, and subjects in the field of Myopia Control. Methods: A search using the keywords “ Myopia Control” was made through Web of Science. Extracted data was analyzed using CitNetExplorer® software obtaining a visual evaluation of the most cited publications. A subnet analysis was made by adding the keywords “ Myopia Control" AND ("orthokeratology" OR "corneal refractive therapy” ), “ Myopia Control" AND ("soft contact lens*" OR "multifocal contact lens*” ), and “ Myopia Control" AND "atropine” . The most important publications of the network and subnetworks were analyzed using the "core" function. Results: This study showed 228 references that generated 1087 citations across the network. 2013 was the most important year for Myopia Control, with most publications and citations. Optometry and Vision Science journal has published the most cited papers. Regarding the authors, Walline ranked the first of the most cited articles on Myopia Control. Conclusion: This study analyzed the associations between the authors, journals and subjects in Myopia Control, highlighting the great importance of this area in the recent years. More than 50% of the papers in the network were published after 2013.

Myopia has become a pandemic disease in the past few years and its sight-threatening consequences associated with high Myopia have been a challenging issue for most public health societies. Controlling Myopia progression has also become a global concern for many people particularly, parents of myopic children. Accordingly, a large body of work has been devoted to considering different optical and non-optical methods to prevent or retard Myopia progression. Different optical strategies such as sunder correction, monofocal spectacles or contact lenses, bifocal or progressive spectacle lenses, multifocal contact lenses, gas-permeable (GP) contact lenses, and orthokeratology (ortho-K) have been proposed to slow down the Myopia progression. Although the effectiveness of these treatment strategies has been vastly studied, there are some debates concerning the most efficient method in Controlling Myopia progression. The present study reviewed the current optical therapies to Control the progression of Myopia. A literature review revealed that optical strategies, such as myopic under correction, monofocal spectacles or contact lenses, GP contact lenses, and bifocal and multifocal spectacle lenses did not provide a clinically significant reduction in Myopia progression. In contrast, ortho-K and newly introduced multifocal soft contact lenses may significantly slow Myopia progression.

Introduction: Concerns about the increasing prevalence of Myopia are because of its rising ocular complications, which in some cases could lead to blindness. Therefore, all practitioners should know the latest updates on Myopia Control in routine practice. Materials and Methods: PubMed, Science Direct, and Google Scholar databases were searched for related scientific articles using search keywords. In this regard, the books and articles published from 2016 to June 2021 were included. The selected articles and valid scientific resources were collected, summarized, classified, evaluated, and finally concluded by the authors. Results: The results of the latest published papers for the prevention of Myopia progression can be summarized as follows: choroidal blood supply as a potential “, rapid predictor indicator”,for the axial elongation, periocular injection of salidroside and formononetin, hyperopic defocus reduction using MiSight contact lenses, the chemical effect of 7-methylxanthine, and the suppressive effect of crocetin dietary supplement. Conclusion: Using the latest methods of Myopia Control alongside conventional strategies has a synergistic effect.

The correlation between Myopia and intraocular inflammation has rarely been explored. The aim of this article is to review myopic changes induced by inflammatory diseases and inflammatory diseases related to Myopia, followed by a discussion on inflammatory choroidal neovascularization. Clinical cases are used to illustrate these conditions. The review does not include inflammatory conditions caused by surgical interventions employed for treatment of Myopia. Uveitic conditions that can induce a myopic shift include sclero-choroidal inflammation, lens induced Myopia due to steroid cataracts, juvenile idiopathic arthritis (JIA) induced Myopia, and transient drug induced Myopia due to sulfonamides and acetazolamide used for treatment of ocular toxoplasmosis and inflammatory cystoid macular edema, respectively. Most inflammatory conditions related to Myopia are conditions involving the choriocapillaris.These include multifocal choroiditis and/or punctate inner choroiditis, multiple evanescent white dot syndrome and acute idiopathic blind spot enlargement. It can be hypothesized that fragility of the choriocapillaris due to particular anatomic changes due to Myopia, together with unknown immunogenetic factors predispose myopic eyes to primary inflammatory choriocapillaropathies.